Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. 2-fluoro-4-(7-((quinolin-6-yl)methyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzoic Acid
2. 2-fluoro-4-(7-((quinolin-6-yl)methyl)imidazo(1,2-b)-(1,2,4)triazin-2-yl)benzamide
3. 2-fluoro-n-methyl-4-(7-((quinolin-6-yl)methyl)imidazo(1,2- B)(1,2,4)triazin-2-yl)benzamide Dihydrochloride Monohydrate
4. 2-fluoro-n-methyl-4-(7-(quinolin-6-yl-methyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzamide
5. 2-fluoro-n-methyl-4-(7-(quinolin-6-ylmethyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzamide
6. 2-fluoro-n-methyl-4-(7-(quinolin-6-ylmethyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzamide Dihydrochloride
7. Capmatinib
8. Capmatinib Dihydrochloride
9. Capmatinib Dihydrochloride Monohydrate
10. Capmatinib Hydrochloride Anhydrous
11. Capmatinib Metabolite M13
12. Capmatinib Metabolite M18
13. Cmc-583
14. Cmc583
15. Cnj-294
16. Cnj294
17. Inc-280
18. Inc280
19. Incb-28060
20. Incb-28060 Free Base
21. Incb28060
22. Nvp-inc280
23. Nvp-inc280-nx
24. Tabrecta
1. 1865733-40-9
2. Nvp-inc280-aaa
3. Capmatinib Hydrochloride [usan]
4. C2a374o70x
5. Capmatinib (dihydrochloride Hydrate)
6. Tabrecta
7. Capmatinib Dihydrochloride Monohydrate
8. Capmatinib Hydrochloride (usan)
9. Capmatinib Hydrochloride Hydrate (jan)
10. 2-fluoro-n-methyl-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl)benzamide Dihydrochloride Hydrate
11. Capmatinib Hydrochloride Hydrate [jan]
12. Tabrecta (tn)
13. Capmatinib 2hcl.h2o
14. Capmatinib 2hcl Hydrate
15. Inc-280 Hydrochloride
16. Incb28060 Hydrochloride
17. Unii-c2a374o70x
18. Capmatinib Hydrochloride Hydrate
19. Chembl3989937
20. Dtxsid401027869
21. Hy-13404c
22. Capmatinib Hydrochloride [who-dd]
23. Capmatinib Hydrochloride Monohydrate
24. Cs-0198834
25. Capmatinib Hydrochloride [orange Book]
26. D10891
27. Q27895918
28. 2-fluoro-n-methyl-4-(7-((quinolin-6-yl)methyl)imidazo(1,2- B)(1,2,4)triazin-2-yl)benzamide Dihydrochloride Monohydrate
29. Benzamide, 2-fluoro-n-methyl-4-(7-(6-quinolinylmethyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)-, Hydrochloride, Hydrate (1:2:1)
Molecular Weight | 503.4 g/mol |
---|---|
Molecular Formula | C23H21Cl2FN6O2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 4 |
Exact Mass | 502.1087075 g/mol |
Monoisotopic Mass | 502.1087075 g/mol |
Topological Polar Surface Area | 86.1 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 637 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
Tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (NSCLC) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (METex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
L01EX17
Global Sales Information
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Capmatinib Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Capmatinib Hydrochloride, including repackagers and relabelers. The FDA regulates Capmatinib Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Capmatinib Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Capmatinib Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Capmatinib Hydrochloride supplier is an individual or a company that provides Capmatinib Hydrochloride active pharmaceutical ingredient (API) or Capmatinib Hydrochloride finished formulations upon request. The Capmatinib Hydrochloride suppliers may include Capmatinib Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Capmatinib Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Capmatinib Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Capmatinib Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Capmatinib Hydrochloride DMFs exist exist since differing nations have different regulations, such as Capmatinib Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Capmatinib Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Capmatinib Hydrochloride USDMF includes data on Capmatinib Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Capmatinib Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Capmatinib Hydrochloride suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Capmatinib Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Capmatinib Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Capmatinib Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Capmatinib Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Capmatinib Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Capmatinib Hydrochloride suppliers with NDC on PharmaCompass.
Capmatinib Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Capmatinib Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Capmatinib Hydrochloride GMP manufacturer or Capmatinib Hydrochloride GMP API supplier for your needs.
A Capmatinib Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Capmatinib Hydrochloride's compliance with Capmatinib Hydrochloride specifications and serves as a tool for batch-level quality control.
Capmatinib Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Capmatinib Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Capmatinib Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Capmatinib Hydrochloride EP), Capmatinib Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Capmatinib Hydrochloride USP).
LOOKING FOR A SUPPLIER?